Multi-omics integration for neuroblastoma clinical endpoint prediction

Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies

(2016) Erika A. Newman et al.   Seminars in Pediatric Surgery

rCGH: a comprehensive array-based genomic profile platform for precision medicine

(2015) Frederic Commo et al.   BIOINFORMATICS

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

(2015) Wenqian Zhang et al.   GENOME BIOLOGY

High Genomic Instability Predicts Survival in Metastatic High-Risk Neuroblastoma

(2015) Sara Stigliani et al.   NEOPLASIA

Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma

(2014) Jessica Theissen et al.   GENES CHROMOSOMES & CANCER

A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium

(2014)   NATURE BIOTECHNOLOGY

Similarity network fusion for aggregating data types on a genomic scale

(2014) Bo Wang et al.   NATURE METHODS

Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma

(2013) H Kocak et al.   Cell Death & Disease

Towards a turning point of neuroblastoma therapy

(2012) Gian Paolo Tonini et al.   CANCER LETTERS

Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma

(2012) Simona Coco et al.   INTERNATIONAL JOURNAL OF CANCER

Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication

(2010) Maija Wolf et al.   BMC CANCER

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

(2010)   NATURE BIOTECHNOLOGY